https://doi.org/10.4081/monaldi.2020.1290
Chloroquine in COVID-19: the evidence
Published: March 31, 2020
Abstract Views: 14779
PDF: 8103
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
The Coronavirus disease 2019 (COVID-19) has been declared as a pandemic by World Health Organisation (WHO). The global mortality has increased, especially in countries like Italy and Iran. With the increasing morbidity and mortality, search for a cure has been the global demand.
How to Cite
Gupta, Nitesh, Sumita Agrawal, and Pranav Ish. 2020. “Chloroquine in COVID-19: The Evidence”. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1290.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Stefania Angela Di Fusco, Furio Colivicchi, Nadia Aspromonte, Marco Tubaro, Alessandro Aiello, Massimo Santini, Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Sumita P. Agrawal, Pranav Ish, Akhil Dhanesh Goel, Nitesh Gupta, Shibdas Chakrabarti, Dipak Bhattacharya, Manas Kamal Sen, Jagdish Chander Suri, Diagnostic utility of endobronchial ultrasound features in differentiating malignant and benign lymph nodes , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Mauro Di Bari, Alessandra Pratesi, Francesca M. Nigro, Irene Marozzi, Stefano Fumagalli, DAPT plus anticoagulant therapy: The difficult coexistence post-ACS in older patients with atrial fibrillation , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Alberto M. Marra, Andrea Salzano, Michele Arcopinto, Lucrezia Piccioli, Valeria Raparelli, The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Danilo Buonsenso, Davide Pata, Arianna Turriziani Colonna, Vittoria Ferrari, Gilda Salerno, Piero Valentini, Vitamin D and tuberculosis in children: a role in the prevention or treatment of the disease? , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Ravi Manglani, Moshe Fenster, Theresa Henson, Ananth Jain, Neil Schluger, Clinical characteristics, imaging, and lung function among patients with persistent dyspnea of COVID-19: a retrospective observational cohort study , Monaldi Archives for Chest Disease: Early Access
- Branko Beronja, Aleksandra Karan, Biljana Lukic, Ivana Milosevic, Jelena Dotlic, Tatjana Gazibara, Authors’ Response , Monaldi Archives for Chest Disease: Early Access
- Antonio Aversa, Andrea Fabbri, Testicular and thyroid function as survival predictors in the elderly patient candidate to surgery , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
- Manas Pratim Roy, Risk factors for Covid-19 in India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Francesco Barillà , Concetta Torromeo, Riccardo Iorio, Luigina Porco, Vincenzo Paravati, Carlo Gaudio, Antiplatelet therapy in elderly patients with acute coronary syndrome: Between scientific evidence and future perspectives , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
